AstraZeneca Vaccine Statement April 2021

JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021: https://www.gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement/jcvi-statement-on-use-of-the-astrazeneca-covid-19-vaccine-7-april-2021

Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine, provided by the University of Cambridge: Weighing up the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine

The AstraZeneca vaccine is approved for use, there are no reports of the extremely rare thrombosis/thrombocytopenia events following receipt of the second dose of the AstraZeneca COVID-19 vaccine. Patients are being encouraged to receive their second dose if they did not experience any problems with their first. The second dose will be important for longer lasting protection against COVID-19.